William Meury Syndax Pharmaceuticals Inc (SNDX) insider trading activity

William Meury is of Syndax Pharmaceuticals Inc. Currently has a direct ownership of 90,000 shares of SNDX, which is worth approximately $1.47 Million. The most recent transaction as insider was on Feb 05, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 90K

38.46% 3M change

38.46% 12M change

Total Value Held $1.47 Million

William Meury Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2025	BUY Grant, award, or other acquisition	-	25,000 Added 21.74%	90,000 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	17,000 Added 20.73%	65,000 Common Stock
Aug 02 2023	SELL Open market or private sale	$1,698,180 $20.46 p/Share	83,000 Reduced 63.36%	48,000 Common Stock
Aug 02 2023	BUY Exercise of conversion of derivative security	$676,450 $8.15 p/Share	83,000 Added 53.55%	72,000 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	16,000 Added 25.0%	48,000 Common Stock
Feb 02 2022	BUY Grant, award, or other acquisition	-	16,000 Added 33.33%	32,000 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	16,000 Added 50.0%	16,000 Common Stock

Also insider at

KRTX

Karuna Therapeutics, Inc. Healthcare

President and CEO

William Meury

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNDX shares.

Notify only if

Value

Insider Trading

Get notified when an Syndax Pharmaceuticals Inc insider buys or sells SNDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Syndax Pharmaceuticals Inc

Track Activities on SNDX

Account